Stamford, CT -- (SBWIRE) -- 08/14/2013 -- OTC Stock Picks is engaged in providing the most up to date and useful information on Hot Penny Stocks poised to breakout. Our newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. These are the awesome penny stocks that the ‘underground penny stock experts’ brag about in our penny stock blogs. Here we bring trending stocks, have a look on: Axa SA (ADR) (OTCMKTS:AXAHY), Invivo Therapeutics Holdings Corp (OTCBB:NVIV), KV Pharmaceutical Co (OTCMKTS:KVPHQ), Liquidmetal Technologies Inc (OTCBB:LQMT)
Axa SA (ADR) (OTCMKTS:AXAHY) started its trading session with the price of $23.28 and closed at $23.30 by scoring -0.51%.
Previous 5 days graph demonstrated an optimistic move of +2.24%. AXAHY’s quarterly performance remained in the green with the percentage of +22.31, while its year to date performance showed that the stock advanced overall +27.88%.
AXAHY’s stocks traded with total volume of 545,469 shares, while the average trading volume remained 95,255 shares. AXA Group, through its subsidiaries, provides insurance and asset management services. Its Life & Savings segment offers term life, whole life, universal life, endowment, deferred and immediate annuities, and other investment-based products, including endowments and savings-related products.
Has AXAHY Found The Bottom and Ready To Move Up? Find Out Here
Invivo Therapeutics Holdings Corp (OTCBB:NVIV) ended its day with the loss of -3.41% and closed at the price of $4.25 after opening at $4.40. Stock traded during its last trading session with the total volume of 217,962 shares, as compared to its average volume of 569,745 shares.
NVIV’s total market capitalization is $333.95 million, along with 78.58 million shares outstanding. The 52 week range of the stock remained $1.25 - $6.20, while its day's lowest price was $4.12 and its hit its day's highest price at $4.50. The beta of NVIV stands at 9.81. Invivo Therapeutics Holdings Corp., a development stage company, focuses on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries, peripheral nerve injuries, and other neurotrauma conditions.
Has NVIV Found The Bottom And Ready To Gain Momentum? Find Out Here
KV Pharmaceutical Co (OTCMKTS:KVPHQ) stock is at $0.195, down -11.36 percent from its previous close of $0.22 The stock opened the session at $0.22 and touched its highest price point at $0.23. KVPHQ stock’s lowest price point for the session stood at $0.19.
Stocks graphical chart shows a bearish trend during its last one month’s trading session. It remained negative -39.06% during the previous three months trade.
Its average trading volume of 3.27 million shares. K-V Pharmaceutical Company operates as a specialty branded pharmaceutical marketing company primarily focusing on women?s health care in the United States. It provides Evamist, a transdermal estrogen therapy, which delivers a low dose of estradiol for the treatment of moderate-to-severe vasomotor symptoms due to menopause.
Why Should Investors Buy KVPHQ After the Recent Fall? Just Go Here and Find Out
Liquidmetal Technologies Inc (OTCBB:LQMT) stock is at $0.147, down -5.16 percent from its previous close of $0.155. Its today’s volume is 4.12 million shares, in comparison to its average trading volume of 16.13 million shares. The stock opened the session at $0.16 and touched its highest price point at $0.16.
LQMT’s lowest price point for the session stood at $0.14 and its 52 week price range stood at $0.05 - $0.33. The company has a total of 305.76 million outstanding shares and its total market capitalization is $44.95 million. Its beta value stands at 1.83 times and earnings per share was $0.09. Liquidmetal Technologies, Inc., a materials technology company, designs, develops, and sells products and components from bulk amorphous alloys worldwide. The company offers components for non-consumer electronic devices, including parts for high end printers, commercial imaging devices, aerospace and defense components, medical devices, automotive components, and industrial machines.
Will LQMT Get Buyers Even After The Recent Rally? Find Out Here
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)